Rectal cancer remains one of the most challenging tumours in respect of local treatment. The many disciplines involved, the development of new insights and novel treatment strategies, and the close correlation between quality of care and outcome provides a fascinating scenario. In this educational session several of these aspects are discussed, and will be of interest to surgeons, radiotherapis...

Correspondence to Dr Yuichiro Ohe; yohe@ ncc. go. jp ESMO Open was launched in January 2016. Since its launch, there have been 199 submissions which have reached a final decision. Due to this impressive acceptance within the community of oncologists, ESMO Open was listed in PubMedCentral within a remarkably short time after the appearance of the first paper (less than 10 months). Apart from imp...

CONTEXT Multiple treatment options are available for men with prostate cancer, but therapeutic recommendations may differ depending on the type of specialist they consult. OBJECTIVE To define and contrast the distribution of management recommendations by urologists and radiation oncologists for a spectrum of men with prostate cancer. DESIGN, SETTING, AND PARTICIPANTS Mail survey sent in 199...

OBJECTIVE Australia has a publicly funded universal healthcare system which heavily subsidises the cost of most registered anticancer drugs. The use of anticancer drugs that are unfunded, that is, not subsidised by the government, entails substantial out-of-pocket costs for patients. We sought to determine how frequently Australian medical oncologists discuss and prescribe unfunded anticancer d...

Abstract INTRODUCTION ClinicalPath is an evidence-based oncology decision support and analytics tool for cancer care. ClinicalPath’s treatment recommendations are prioritized based on efficacy, toxicity, cost by a nationwide committee of oncologists. The pathways updated quarterly expected to speed the integration new treatments into practice, standardize therapy, improve quality, decrease cost...

BACKGROUND This exploratory study investigated the motives of medical students (N = 63) for using indirect questions of the type I don't know if [you have already heard about chemotherapies], I don't know how [you are], or I don't know what [you do for a living] in simulated patient interviews during a communication skills course. METHODS I don't know questions (IDK-Qs) were observed during t...

Difficult conversations about prognosis, end of life, and goals of care arise commonly in medical oncology practice. These conversations are often highly emotional. Medical oncologists need outstanding, patient-centered communication skills to build trust and rapport with their patients and help them make well-informed decisions. Key skills include exploring patients' perspectives, responding t...